Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Steger

Showing results (221-230 of 320) with videos related to

Pageof 32
Sort By:
Cancer Immunology, Immunotherapy : CII|September 22, 2000
Sequential administration of interferon gamma and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial. Austrian Renal Cell Carcinoma Study GroupM Schmidinger, G G Steger, C Wenzel, et al.
Diabetes, Nutrition & Metabolism|April 27, 2000
Effects of acarbose treatment in Type 2 diabetic patients under dietary training: a multicentre, double-blind, placebo-controlled, 2-year studyH Hasche, G Mertes, C Bruns, et al.
Wiener Klinische Wochenschrift|September 29, 2000
Glutathione in the prevention of cisplatin induced toxicities. A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancerM Schmidinger, A C Budinsky, C Wenzel, et al.
Anti-Cancer Drugs|November 18, 2000
Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancerT Brodowicz, R M Wolfram, W J Köstler, et al.
Breast Cancer Research and Treatment|October 10, 2006
Results from an observational trial with oral vinorelbine and trastuzumab in advanced breast cancerRupert Bartsch, Catharina Wenzel, Gabriela Altorjai, et al.
Journal of Cancer Research and Clinical Oncology|May 29, 2004
Preoperative therapy with epidoxorubicin and docetaxel plus trastuzumab in patients with primary breast cancer: a pilot studyCatharina Wenzel, Dagmar Hussian, Rupert Bartsch, et al.
Anti-Cancer Drugs|March 5, 2005
Preoperative chemotherapy with epidoxorubicin, docetaxel and capecitabine plus pegfilgrastim in patients with primary breast cancerCatharina Wenzel, Rupert Bartsch, Gottfried J Locker, et al.
British Journal of Cancer|September 11, 2003
Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatmentG Hudelist, W J Köstler, J Attems, et al.
Cancer Chemotherapy and Pharmacology|November 22, 2018
Metastatic or locally advanced breast cancer patients: towards an expert consensus on nab-paclitaxel treatment in HER2-negative tumours-the MACBETH projectMarina E Cazzaniga, E Ciruelos, A Fabi, et al.
Wiener Klinische Wochenschrift|July 1, 2005
Preoperative second-line chemotherapy induces objective responses in primary breast cancerCatharina Wenzel, Gottfried J Locker, Rupert Bartsch, et al.
Pageof 32

Showing results (221-230 of 320) with videos related to

Sort By:
Pageof 32
Cancer Immunology, Immunotherapy : CII|September 22, 2000
Sequential administration of interferon gamma and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial. Austrian Renal Cell Carcinoma Study GroupM Schmidinger, G G Steger, C Wenzel, et al.
Diabetes, Nutrition & Metabolism|April 27, 2000
Effects of acarbose treatment in Type 2 diabetic patients under dietary training: a multicentre, double-blind, placebo-controlled, 2-year studyH Hasche, G Mertes, C Bruns, et al.
Wiener Klinische Wochenschrift|September 29, 2000
Glutathione in the prevention of cisplatin induced toxicities. A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancerM Schmidinger, A C Budinsky, C Wenzel, et al.
Anti-Cancer Drugs|November 18, 2000
Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancerT Brodowicz, R M Wolfram, W J Köstler, et al.
Breast Cancer Research and Treatment|October 10, 2006
Results from an observational trial with oral vinorelbine and trastuzumab in advanced breast cancerRupert Bartsch, Catharina Wenzel, Gabriela Altorjai, et al.
Journal of Cancer Research and Clinical Oncology|May 29, 2004
Preoperative therapy with epidoxorubicin and docetaxel plus trastuzumab in patients with primary breast cancer: a pilot studyCatharina Wenzel, Dagmar Hussian, Rupert Bartsch, et al.
Anti-Cancer Drugs|March 5, 2005
Preoperative chemotherapy with epidoxorubicin, docetaxel and capecitabine plus pegfilgrastim in patients with primary breast cancerCatharina Wenzel, Rupert Bartsch, Gottfried J Locker, et al.
British Journal of Cancer|September 11, 2003
Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatmentG Hudelist, W J Köstler, J Attems, et al.
Cancer Chemotherapy and Pharmacology|November 22, 2018
Metastatic or locally advanced breast cancer patients: towards an expert consensus on nab-paclitaxel treatment in HER2-negative tumours-the MACBETH projectMarina E Cazzaniga, E Ciruelos, A Fabi, et al.
Wiener Klinische Wochenschrift|July 1, 2005
Preoperative second-line chemotherapy induces objective responses in primary breast cancerCatharina Wenzel, Gottfried J Locker, Rupert Bartsch, et al.
Pageof 32